“…Several activators were identified upstream of Ras. In addition to canonical signals from the EGF receptor (EGFR) through SHC/GRB2/SOS phosphorylation, other upstream activators contain ETV4 [108], Ras-related protein 25 (Rab25) through Src [109], RasGRP3, which naturally activates Ras via helping Ras-GDP release and that could be promoted by endothelin A receptor (ET A R) [110,111], E-selectin ligand 1 (ESL-1), which controls the rolling capacity of circulating PCa cells [112], miR-let-7c, which possibly promotes c-Myc [113][114][115], miR-407, which is secreted by cancer-associated fibroblasts that block Ras suppressor 1 (RSU-1) [116], Ras and a-factor-converting enzyme 1 (Rce1) by acting on prenylation that works on Ras anchoring [117,118], EZH2 by blocking disabled homolog 2-interacting protein (DAB2IP), a GTPase-activating protein that converts Ras-GTP to Ras-GDP, and stabilizes HIF-1α for the EMT [119][120][121], and the oxytocin receptor (OXTR) by coupling with the EGFR [122]. In contrast, to retard Ras signaling during PCa metastasis, only miR-145 [123] and phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG)/RasGAP [124] were identified.…”